ATAD2_HUMAN - dbPTM
ATAD2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ATAD2_HUMAN
UniProt AC Q6PL18
Protein Name ATPase family AAA domain-containing protein 2
Gene Name ATAD2
Organism Homo sapiens (Human).
Sequence Length 1390
Subcellular Localization Nucleus .
Protein Description May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells..
Protein Sequence MVVLRSSLELHNHSAASATGSLDLSSDFLSLEHIGRRRLRSAGAAQKKPAATTAKAGDGSSVKEVETYHRTRALRSLRKDAQNSSDSSFEKNVEITEQLANGRHFTRQLARQQADKKKEEHREDKVIPVTRSLRARNIVQSTEHLHEDNGDVEVRRSCRIRSRYSGVNQSMLFDKLITNTAEAVLQKMDDMKKMRRQRMRELEDLGVFNETEESNLNMYTRGKQKDIQRTDEETTDNQEGSVESSEEGEDQEHEDDGEDEDDEDDDDDDDDDDDDDDEDDEDEEDGEEENQKRYYLRQRKATVYYQAPLEKPRHQRKPNIFYSGPASPARPRYRLSSAGPRSPYCKRMNRRRHAIHSSDSTSSSSSEDEQHFERRRKRSRNRAINRCLPLNFRKDELKGIYKDRMKIGASLADVDPMQLDSSVRFDSVGGLSNHIAALKEMVVFPLLYPEVFEKFKIQPPRGCLFYGPPGTGKTLVARALANECSQGDKRVAFFMRKGADCLSKWVGESERQLRLLFDQAYQMRPSIIFFDEIDGLAPVRSSRQDQIHSSIVSTLLALMDGLDSRGEIVVIGATNRLDSIDPALRRPGRFDREFLFSLPDKEARKEILKIHTRDWNPKPLDTFLEELAENCVGYCGADIKSICAEAALCALRRRYPQIYTTSEKLQLDLSSINISAKDFEVAMQKMIPASQRAVTSPGQALSTVVKPLLQNTVDKILEALQRVFPHAEFRTNKTLDSDISCPLLESDLAYSDDDVPSVYENGLSQKSSHKAKDNFNFLHLNRNACYQPMSFRPRILIVGEPGFGQGSHLAPAVIHALEKFTVYTLDIPVLFGVSTTSPEETCAQVIREAKRTAPSIVYVPHIHVWWEIVGPTLKATFTTLLQNIPSFAPVLLLATSDKPHSALPEEVQELFIRDYGEIFNVQLPDKEERTKFFEDLILKQAAKPPISKKKAVLQALEVLPVAPPPEPRSLTAEEVKRLEEQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESRKKRGCSSSKYAPSYYHVMPKQNSTLVGDKRSDPEQNEKLKTPSTPVACSTPAQLKRKIRKKSNWYLGTIKKRRKISQAKDDSQNAIDHKIESDTEETQDTSVDHNETGNTGESSVEENEKQQNASESKLELRNNSNTCNIENELEDSRKTTACTELRDKIACNGDASSSQIIHISDENEGKEMCVLRMTRARRSQVEQQQLITVEKALAILSQPTPSLVVDHERLKNLLKTVVKKSQNYNIFQLENLYAVISQCIYRHRKDHDKTSLIQKMEQEVENFSCSR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MVVLRSSLELHNH
--CEEECCCEEECCC
34.8028122231
7Phosphorylation-MVVLRSSLELHNHS
-CEEECCCEEECCCC
21.3028122231
14PhosphorylationSLELHNHSAASATGS
CEEECCCCCCCCCCC
30.7428122231
17PhosphorylationLHNHSAASATGSLDL
ECCCCCCCCCCCCCC
26.5322468782
19PhosphorylationNHSAASATGSLDLSS
CCCCCCCCCCCCCCC
25.4722468782
21PhosphorylationSAASATGSLDLSSDF
CCCCCCCCCCCCCCC
17.8522468782
26PhosphorylationTGSLDLSSDFLSLEH
CCCCCCCCCCCCHHH
39.4128122231
41PhosphorylationIGRRRLRSAGAAQKK
HHHHHHHHCCCCCCC
35.3330266825
47AcetylationRSAGAAQKKPAATTA
HHCCCCCCCCCCCEE
56.8725953088
48UbiquitinationSAGAAQKKPAATTAK
HCCCCCCCCCCCEEE
28.01-
55AcetylationKPAATTAKAGDGSSV
CCCCCEEECCCCCCH
51.3025953088
55UbiquitinationKPAATTAKAGDGSSV
CCCCCEEECCCCCCH
51.3021906983
55 (in isoform 1)Ubiquitination-51.3021890473
60PhosphorylationTAKAGDGSSVKEVET
EEECCCCCCHHHHHH
36.3830266825
61PhosphorylationAKAGDGSSVKEVETY
EECCCCCCHHHHHHH
42.6223401153
63AcetylationAGDGSSVKEVETYHR
CCCCCCHHHHHHHHH
58.9726051181
63UbiquitinationAGDGSSVKEVETYHR
CCCCCCHHHHHHHHH
58.9721906983
63 (in isoform 1)Ubiquitination-58.9721890473
67PhosphorylationSSVKEVETYHRTRAL
CCHHHHHHHHHHHHH
29.7823312004
68PhosphorylationSVKEVETYHRTRALR
CHHHHHHHHHHHHHH
3.9323312004
76PhosphorylationHRTRALRSLRKDAQN
HHHHHHHHHHHHHHC
33.1226670566
79UbiquitinationRALRSLRKDAQNSSD
HHHHHHHHHHHCCCC
63.8121906983
79 (in isoform 1)Ubiquitination-63.8121890473
84PhosphorylationLRKDAQNSSDSSFEK
HHHHHHCCCCCCHHH
24.3623663014
85PhosphorylationRKDAQNSSDSSFEKN
HHHHHCCCCCCHHHH
49.4125159151
87PhosphorylationDAQNSSDSSFEKNVE
HHHCCCCCCHHHHHH
38.5829255136
88PhosphorylationAQNSSDSSFEKNVEI
HHCCCCCCHHHHHHH
42.2729255136
91UbiquitinationSSDSSFEKNVEITEQ
CCCCCHHHHHHHHHH
65.3721906983
91 (in isoform 1)Ubiquitination-65.3721890473
96PhosphorylationFEKNVEITEQLANGR
HHHHHHHHHHHHCCH
12.2723663014
125SumoylationKEEHREDKVIPVTRS
HHHHHHCCCCCHHHH
36.9928112733
130PhosphorylationEDKVIPVTRSLRARN
HCCCCCHHHHHHHHC
14.8023828894
132PhosphorylationKVIPVTRSLRARNIV
CCCCHHHHHHHHCHH
16.9117924679
141PhosphorylationRARNIVQSTEHLHED
HHHCHHHHCCHHCCC
25.5223401153
141 (in isoform 2)Ubiquitination-25.5221890473
142PhosphorylationARNIVQSTEHLHEDN
HHCHHHHCCHHCCCC
15.4430266825
157PhosphorylationGDVEVRRSCRIRSRY
CCCHHHHHCCCCCCC
9.3617081983
162PhosphorylationRRSCRIRSRYSGVNQ
HHHCCCCCCCCCCCH
32.9523401153
164PhosphorylationSCRIRSRYSGVNQSM
HCCCCCCCCCCCHHH
15.8328450419
165PhosphorylationCRIRSRYSGVNQSML
CCCCCCCCCCCHHHH
34.8425159151
170AcetylationRYSGVNQSMLFDKLI
CCCCCCHHHHHHHHH
16.5519608861
170PhosphorylationRYSGVNQSMLFDKLI
CCCCCCHHHHHHHHH
16.5530266825
175AcetylationNQSMLFDKLITNTAE
CHHHHHHHHHHHHHH
34.1619608861
175UbiquitinationNQSMLFDKLITNTAE
CHHHHHHHHHHHHHH
34.1619608861
187AcetylationTAEAVLQKMDDMKKM
HHHHHHHHHHHHHHH
39.8919608861
187UbiquitinationTAEAVLQKMDDMKKM
HHHHHHHHHHHHHHH
39.8919608861
211PhosphorylationDLGVFNETEESNLNM
HHCCCCCCCCCCCHH
46.2730576142
214PhosphorylationVFNETEESNLNMYTR
CCCCCCCCCCHHHCC
40.1430576142
220PhosphorylationESNLNMYTRGKQKDI
CCCCHHHCCCCHHCC
23.3728122231
236 (in isoform 2)Ubiquitination-63.3321890473
300UbiquitinationRYYLRQRKATVYYQA
HHHHHHHCCEEEEEC
39.82-
302PhosphorylationYLRQRKATVYYQAPL
HHHHHCCEEEEECCC
16.4520068231
304PhosphorylationRQRKATVYYQAPLEK
HHHCCEEEEECCCCC
5.87-
305PhosphorylationQRKATVYYQAPLEKP
HHCCEEEEECCCCCC
8.2125159151
311AcetylationYYQAPLEKPRHQRKP
EEECCCCCCCCCCCC
55.8426051181
311UbiquitinationYYQAPLEKPRHQRKP
EEECCCCCCCCCCCC
55.8421890473
311 (in isoform 1)Ubiquitination-55.8421890473
317SumoylationEKPRHQRKPNIFYSG
CCCCCCCCCCEEECC
35.5328112733
322PhosphorylationQRKPNIFYSGPASPA
CCCCCEEECCCCCCC
14.6623927012
323PhosphorylationRKPNIFYSGPASPAR
CCCCEEECCCCCCCC
27.7929255136
327PhosphorylationIFYSGPASPARPRYR
EEECCCCCCCCCCCC
23.4029255136
333PhosphorylationASPARPRYRLSSAGP
CCCCCCCCCCCCCCC
20.7023186163
336PhosphorylationARPRYRLSSAGPRSP
CCCCCCCCCCCCCCH
14.7827273156
337PhosphorylationRPRYRLSSAGPRSPY
CCCCCCCCCCCCCHH
41.6623401153
342PhosphorylationLSSAGPRSPYCKRMN
CCCCCCCCHHHHHHH
24.2922167270
344PhosphorylationSAGPRSPYCKRMNRR
CCCCCCHHHHHHHHC
16.3223927012
360PhosphorylationHAIHSSDSTSSSSSE
CCCCCCCCCCCCCCH
31.9425814448
361PhosphorylationAIHSSDSTSSSSSED
CCCCCCCCCCCCCHH
37.3025814448
362PhosphorylationIHSSDSTSSSSSEDE
CCCCCCCCCCCCHHH
31.9825814448
372 (in isoform 2)Phosphorylation-8.5824260401
379PhosphorylationFERRRKRSRNRAINR
HHHHHHHHHHHHHHH
36.6222817900
398UbiquitinationNFRKDELKGIYKDRM
CCCHHHHCCHHHCCC
41.01-
406UbiquitinationGIYKDRMKIGASLAD
CHHHCCCCCCCCCCC
38.5921906983
406 (in isoform 1)Ubiquitination-38.5921890473
410PhosphorylationDRMKIGASLADVDPM
CCCCCCCCCCCCCHH
20.9123186163
421PhosphorylationVDPMQLDSSVRFDSV
CCHHHCCCCCCCCCC
39.0523186163
422PhosphorylationDPMQLDSSVRFDSVG
CHHHCCCCCCCCCCC
19.5823186163
456UbiquitinationPEVFEKFKIQPPRGC
HHHHHHCCCCCCCCE
52.04-
473UbiquitinationYGPPGTGKTLVARAL
ECCCCCCHHHHHHHH
38.22-
489AcetylationNECSQGDKRVAFFMR
HHCCCCCHHHHHHHH
56.4426051181
489UbiquitinationNECSQGDKRVAFFMR
HHCCCCCHHHHHHHH
56.44-
497UbiquitinationRVAFFMRKGADCLSK
HHHHHHHHCHHHHHH
46.81-
504AcetylationKGADCLSKWVGESER
HCHHHHHHHCCCCHH
32.7126051181
504UbiquitinationKGADCLSKWVGESER
HCHHHHHHHCCCCHH
32.71-
579PhosphorylationGATNRLDSIDPALRR
ECCCCHHCCCHHHCC
33.2223186163
601UbiquitinationFLFSLPDKEARKEIL
HHHCCCCHHHHHHHH
51.8621906983
601 (in isoform 1)Ubiquitination-51.8621890473
609UbiquitinationEARKEILKIHTRDWN
HHHHHHHHHHHCCCC
37.80-
670PhosphorylationEKLQLDLSSINISAK
CCEECCHHHCCCCHH
28.9225159151
671PhosphorylationKLQLDLSSINISAKD
CEECCHHHCCCCHHH
27.2723663014
677UbiquitinationSSINISAKDFEVAMQ
HHCCCCHHHHHHHHH
57.04-
685UbiquitinationDFEVAMQKMIPASQR
HHHHHHHHHCCHHHC
26.2221906983
685 (in isoform 1)Ubiquitination-26.2221890473
695PhosphorylationPASQRAVTSPGQALS
CHHHCCCCCHHHHHH
28.3720068231
696PhosphorylationASQRAVTSPGQALST
HHHCCCCCHHHHHHH
22.0427067055
706UbiquitinationQALSTVVKPLLQNTV
HHHHHHHHHHHHHHH
26.1321906983
706 (in isoform 1)Ubiquitination-26.1321890473
734PhosphorylationAEFRTNKTLDSDISC
CHHCCCCCCCCCCCC
37.5620873877
737PhosphorylationRTNKTLDSDISCPLL
CCCCCCCCCCCCCCC
39.7020873877
740PhosphorylationKTLDSDISCPLLESD
CCCCCCCCCCCCCCH
18.0520873877
746PhosphorylationISCPLLESDLAYSDD
CCCCCCCCHHCCCCC
37.5825159151
750PhosphorylationLLESDLAYSDDDVPS
CCCCHHCCCCCCCCH
21.6728102081
751PhosphorylationLESDLAYSDDDVPSV
CCCHHCCCCCCCCHH
29.0225159151
757PhosphorylationYSDDDVPSVYENGLS
CCCCCCCHHHHCCCC
36.8623663014
759PhosphorylationDDDVPSVYENGLSQK
CCCCCHHHHCCCCCC
14.1723663014
764PhosphorylationSVYENGLSQKSSHKA
HHHHCCCCCCCCCCC
36.6420068231
767PhosphorylationENGLSQKSSHKAKDN
HCCCCCCCCCCCCCC
30.0026074081
768PhosphorylationNGLSQKSSHKAKDNF
CCCCCCCCCCCCCCC
35.7226074081
772AcetylationQKSSHKAKDNFNFLH
CCCCCCCCCCCCEEE
58.9923749302
772UbiquitinationQKSSHKAKDNFNFLH
CCCCCCCCCCCCEEE
58.99-
790PhosphorylationNACYQPMSFRPRILI
CCCCCCCCCCCEEEE
25.4524719451
852PhosphorylationVIREAKRTAPSIVYV
HHHHHHHHCCCEEEE
42.06-
855PhosphorylationEAKRTAPSIVYVPHI
HHHHHCCCEEEECEE
23.40-
858PhosphorylationRTAPSIVYVPHIHVW
HHCCCEEEECEEEEH
13.44-
926UbiquitinationFNVQLPDKEERTKFF
HCEECCCHHHHHHHH
60.5821906983
926 (in isoform 1)Ubiquitination-60.5821890473
931UbiquitinationPDKEERTKFFEDLIL
CCHHHHHHHHHHHHH
55.0321890473
931 (in isoform 1)Ubiquitination-55.0321890473
939UbiquitinationFFEDLILKQAAKPPI
HHHHHHHHHHCCCCC
30.78-
949UbiquitinationAKPPISKKKAVLQAL
CCCCCCHHHHHHHHH
38.89-
950UbiquitinationKPPISKKKAVLQALE
CCCCCHHHHHHHHHH
47.68-
969PhosphorylationAPPPEPRSLTAEEVK
CCCCCCCCCCHHHHH
40.5625849741
971PhosphorylationPPEPRSLTAEEVKRL
CCCCCCCCHHHHHHH
33.0119691289
976UbiquitinationSLTAEEVKRLEEQEE
CCCHHHHHHHHHHHH
55.3221906983
976 (in isoform 1)Ubiquitination-55.3221890473
997PhosphorylationRIFLRNVTHRLAIDK
HHHHHHHHHHHHHCC
12.5824719451
1011UbiquitinationKRFRVFTKPVDPDEV
CCEEEECCCCCCCCC
31.4221906983
1011 (in isoform 1)Ubiquitination-31.4221890473
1021PhosphorylationDPDEVPDYVTVIKQP
CCCCCCCCEEEECCC
7.6128796482
1023PhosphorylationDEVPDYVTVIKQPMD
CCCCCCEEEECCCCC
15.4128796482
1026UbiquitinationPDYVTVIKQPMDLSS
CCCEEEECCCCCHHH
43.9721906983
1026 (in isoform 1)Ubiquitination-43.9721890473
1032O-linked_GlycosylationIKQPMDLSSVISKID
ECCCCCHHHHHHHCC
20.49OGP
1032PhosphorylationIKQPMDLSSVISKID
ECCCCCHHHHHHHCC
20.4926074081
1033O-linked_GlycosylationKQPMDLSSVISKIDL
CCCCCHHHHHHHCCH
30.66OGP
1033PhosphorylationKQPMDLSSVISKIDL
CCCCCHHHHHHHCCH
30.6626074081
1036PhosphorylationMDLSSVISKIDLHKY
CCHHHHHHHCCHHHH
22.7726074081
1037UbiquitinationDLSSVISKIDLHKYL
CHHHHHHHCCHHHHC
29.17-
1042UbiquitinationISKIDLHKYLTVKDY
HHHCCHHHHCCHHHH
49.6121890473
1042 (in isoform 1)Ubiquitination-49.6121890473
1043PhosphorylationSKIDLHKYLTVKDYL
HHCCHHHHCCHHHHH
9.2526074081
1045PhosphorylationIDLHKYLTVKDYLRD
CCHHHHCCHHHHHHH
23.5524719451
1047UbiquitinationLHKYLTVKDYLRDID
HHHHCCHHHHHHHHH
35.11-
1049PhosphorylationKYLTVKDYLRDIDLI
HHCCHHHHHHHHHHH
9.6426074081
1058PhosphorylationRDIDLICSNALEYNP
HHHHHHCCCCHHCCC
20.3926074081
1063PhosphorylationICSNALEYNPDRDPG
HCCCCHHCCCCCCCC
32.61-
1084PhosphorylationRACALRDTAYAIIKE
HHHHHHHHHHHHHHH
18.3520068231
1086PhosphorylationCALRDTAYAIIKEEL
HHHHHHHHHHHHHHC
10.6320068231
1090SumoylationDTAYAIIKEELDEDF
HHHHHHHHHHCHHHH
38.74-
1117AcetylationKRGCSSSKYAPSYYH
HCCCCCCCCCCCEEE
47.5925953088
1117UbiquitinationKRGCSSSKYAPSYYH
HCCCCCCCCCCCEEE
47.59-
1118PhosphorylationRGCSSSKYAPSYYHV
CCCCCCCCCCCEEEE
26.2028555341
1121PhosphorylationSSSKYAPSYYHVMPK
CCCCCCCCEEEECCC
30.1028555341
1122PhosphorylationSSKYAPSYYHVMPKQ
CCCCCCCEEEECCCC
9.1327642862
1128SumoylationSYYHVMPKQNSTLVG
CEEEECCCCCCCCCC
43.9728112733
1128UbiquitinationSYYHVMPKQNSTLVG
CEEEECCCCCCCCCC
43.97-
1131PhosphorylationHVMPKQNSTLVGDKR
EECCCCCCCCCCCCC
22.1830576142
1132PhosphorylationVMPKQNSTLVGDKRS
ECCCCCCCCCCCCCC
32.7730108239
1137UbiquitinationNSTLVGDKRSDPEQN
CCCCCCCCCCCHHHH
48.12-
1139PhosphorylationTLVGDKRSDPEQNEK
CCCCCCCCCHHHHHC
64.3625159151
1146UbiquitinationSDPEQNEKLKTPSTP
CCHHHHHCCCCCCCC
63.9321906983
1146 (in isoform 1)Ubiquitination-63.9321890473
1148SumoylationPEQNEKLKTPSTPVA
HHHHHCCCCCCCCCC
70.2528112733
1148UbiquitinationPEQNEKLKTPSTPVA
HHHHHCCCCCCCCCC
70.25-
1149PhosphorylationEQNEKLKTPSTPVAC
HHHHCCCCCCCCCCC
32.6725159151
1151PhosphorylationNEKLKTPSTPVACST
HHCCCCCCCCCCCCC
51.0425159151
1152PhosphorylationEKLKTPSTPVACSTP
HCCCCCCCCCCCCCH
24.0025159151
1157PhosphorylationPSTPVACSTPAQLKR
CCCCCCCCCHHHHHH
27.9125159151
1158PhosphorylationSTPVACSTPAQLKRK
CCCCCCCCHHHHHHH
23.6425159151
1163UbiquitinationCSTPAQLKRKIRKKS
CCCHHHHHHHHHHCC
39.30-
1170PhosphorylationKRKIRKKSNWYLGTI
HHHHHHCCCCCHHHH
35.3120873877
1173PhosphorylationIRKKSNWYLGTIKKR
HHHCCCCCHHHHHHH
10.2527642862
1176PhosphorylationKSNWYLGTIKKRRKI
CCCCCHHHHHHHHCH
27.3320873877
1184PhosphorylationIKKRRKISQAKDDSQ
HHHHHCHHHCCCCCC
27.4120873877
1190PhosphorylationISQAKDDSQNAIDHK
HHHCCCCCCHHHCCC
35.1529255136
1200PhosphorylationAIDHKIESDTEETQD
HHCCCCCCCCCCCCC
53.9922167270
1202PhosphorylationDHKIESDTEETQDTS
CCCCCCCCCCCCCCC
45.0322167270
1205PhosphorylationIESDTEETQDTSVDH
CCCCCCCCCCCCCCC
26.0528450419
1208PhosphorylationDTEETQDTSVDHNET
CCCCCCCCCCCCCCC
22.3428450419
1209PhosphorylationTEETQDTSVDHNETG
CCCCCCCCCCCCCCC
33.5630576142
1215PhosphorylationTSVDHNETGNTGESS
CCCCCCCCCCCCCCC
40.8430576142
1218PhosphorylationDHNETGNTGESSVEE
CCCCCCCCCCCCHHH
43.6130576142
1221PhosphorylationETGNTGESSVEENEK
CCCCCCCCCHHHHHH
40.8220363803
1222PhosphorylationTGNTGESSVEENEKQ
CCCCCCCCHHHHHHH
29.2820363803
1233PhosphorylationNEKQQNASESKLELR
HHHHHCCCHHHHHHH
50.3730266825
1235PhosphorylationKQQNASESKLELRNN
HHHCCCHHHHHHHCC
39.7930266825
1236SumoylationQQNASESKLELRNNS
HHCCCHHHHHHHCCC
41.7628112733
1236UbiquitinationQQNASESKLELRNNS
HHCCCHHHHHHHCCC
41.7621906983
1236 (in isoform 1)Ubiquitination-41.7621890473
1243PhosphorylationKLELRNNSNTCNIEN
HHHHHCCCCCCCCCH
36.7425159151
1245PhosphorylationELRNNSNTCNIENEL
HHHCCCCCCCCCHHH
13.5230266825
1255PhosphorylationIENELEDSRKTTACT
CCHHHHHHHCCHHCH
26.7125159151
1257UbiquitinationNELEDSRKTTACTEL
HHHHHHHCCHHCHHH
54.93-
1258PhosphorylationELEDSRKTTACTELR
HHHHHHCCHHCHHHH
20.6530108239
1259PhosphorylationLEDSRKTTACTELRD
HHHHHCCHHCHHHHH
23.8330108239
1262PhosphorylationSRKTTACTELRDKIA
HHCCHHCHHHHHHHC
35.2730108239
1267UbiquitinationACTELRDKIACNGDA
HCHHHHHHHCCCCCC
26.26-
1275PhosphorylationIACNGDASSSQIIHI
HCCCCCCCCCCEEEE
34.9530576142
1276PhosphorylationACNGDASSSQIIHIS
CCCCCCCCCCEEEEE
28.1630576142
1277PhosphorylationCNGDASSSQIIHISD
CCCCCCCCCEEEEEC
23.9325850435
1283PhosphorylationSSQIIHISDENEGKE
CCCEEEEECCCCCCE
25.3930266825
1289AcetylationISDENEGKEMCVLRM
EECCCCCCEEEHHHH
35.7826051181
1302PhosphorylationRMTRARRSQVEQQQL
HHHHHHHHHHHHHHC
32.7825159151
1311PhosphorylationVEQQQLITVEKALAI
HHHHHCHHHHHHHHH
31.0728111955
1314UbiquitinationQQLITVEKALAILSQ
HHCHHHHHHHHHHHC
44.352190698
1314 (in isoform 1)Ubiquitination-44.3521890473
1323PhosphorylationLAILSQPTPSLVVDH
HHHHHCCCCCEEECH
20.2028112733
1372UbiquitinationRHRKDHDKTSLIQKM
HCCCCCCCCHHHHHH
36.27-
1378UbiquitinationDKTSLIQKMEQEVEN
CCCHHHHHHHHHHHH
37.09-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ATAD2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ATAD2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ATAD2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MYC_HUMANMYCphysical
19843847
NCOA3_HUMANNCOA3physical
17998543
ESR1_HUMANESR1physical
17998543
H31T_HUMANHIST3H3physical
20855524
SPTN2_HUMANSPTBN2physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ATAD2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-170 AND SER-1302, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1158 AND SER-1243, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-746; SER-751; THR-1149;THR-1152; THR-1158 AND SER-1302, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1302, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-342 AND SER-1243, ANDMASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-751, AND MASSSPECTROMETRY.

TOP